rs509360
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001127392.3(MYRF):c.2572+42A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.627 in 1,610,482 control chromosomes in the GnomAD database, including 334,631 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.52 ( 24932 hom., cov: 32)
Exomes 𝑓: 0.64 ( 309699 hom. )
Consequence
MYRF
NM_001127392.3 intron
NM_001127392.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.14
Genes affected
MYRF (HGNC:1181): (myelin regulatory factor) This gene encodes a transcription factor that is required for central nervous system myelination and may regulate oligodendrocyte differentiation. It is thought to act by increasing the expression of genes that effect myelin production but may also directly promote myelin gene expression. Loss of a similar gene in mouse models results in severe demyelination. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 11-61781087-A-G is Benign according to our data. Variant chr11-61781087-A-G is described in ClinVar as [Benign]. Clinvar id is 1272274.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.731 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.525 AC: 79640AN: 151828Hom.: 24916 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
79640
AN:
151828
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.608 AC: 151310AN: 248854 AF XY: 0.596 show subpopulations
GnomAD2 exomes
AF:
AC:
151310
AN:
248854
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.638 AC: 930679AN: 1458536Hom.: 309699 Cov.: 48 AF XY: 0.628 AC XY: 455550AN XY: 725740 show subpopulations
GnomAD4 exome
AF:
AC:
930679
AN:
1458536
Hom.:
Cov.:
48
AF XY:
AC XY:
455550
AN XY:
725740
Gnomad4 AFR exome
AF:
AC:
5202
AN:
33472
Gnomad4 AMR exome
AF:
AC:
36886
AN:
44704
Gnomad4 ASJ exome
AF:
AC:
18675
AN:
26118
Gnomad4 EAS exome
AF:
AC:
18521
AN:
39670
Gnomad4 SAS exome
AF:
AC:
25870
AN:
86250
Gnomad4 FIN exome
AF:
AC:
32791
AN:
50420
Gnomad4 NFE exome
AF:
AC:
751149
AN:
1111784
Gnomad4 Remaining exome
AF:
AC:
37829
AN:
60354
Heterozygous variant carriers
0
20411
40822
61232
81643
102054
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
19072
38144
57216
76288
95360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.524 AC: 79671AN: 151946Hom.: 24932 Cov.: 32 AF XY: 0.524 AC XY: 38909AN XY: 74288 show subpopulations
GnomAD4 genome
AF:
AC:
79671
AN:
151946
Hom.:
Cov.:
32
AF XY:
AC XY:
38909
AN XY:
74288
Gnomad4 AFR
AF:
AC:
0.175018
AN:
0.175018
Gnomad4 AMR
AF:
AC:
0.742539
AN:
0.742539
Gnomad4 ASJ
AF:
AC:
0.717867
AN:
0.717867
Gnomad4 EAS
AF:
AC:
0.563809
AN:
0.563809
Gnomad4 SAS
AF:
AC:
0.292602
AN:
0.292602
Gnomad4 FIN
AF:
AC:
0.638316
AN:
0.638316
Gnomad4 NFE
AF:
AC:
0.668487
AN:
0.668487
Gnomad4 OTH
AF:
AC:
0.604167
AN:
0.604167
Heterozygous variant carriers
0
1592
3184
4777
6369
7961
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
650
1300
1950
2600
3250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1608
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 13, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at